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Abstract
Introduction: Insulin is one of the major factors regulating adipose tissue function. On the other hand, adipocytes secrete adipocytokines 
that may influence insulin synthesis and action, and are involved in blood glucose regulation. In type 1 diabetes mellitus (t1DM), beta 
cells function is replaced with exogenous insulin therapy. This raises a question concerning the impact of t1DM on adipose tissue secre-
tory function. The aim of this study was to evaluate one of the adipocytokines, resistin, serum concentrations in relation to body fat mass 
in children with t1DM.
Material and methods: The study comprised 75 children with t1DM and a control group of 20 healthy coevals. All children had estimated 
serum resistin concentrations, glycated haemoglobin levels, growth and body weight measurements, and bioelectrical impedance analysis 
in order to establish body composition.
Results: Resistin serum concentrations were significantly lower in children with t1DM vs. controls (median values: 343 vs. 590 pg/mL; 
mean values ± SD: 577 ± 561 vs. 861 ± 628 pg/mL; p < 0.001), and they negatively correlated with body fat mass (p = 0.022) and age 
(p = 0.022) in the t1DM group, but not in the control group. Disease duration, glycated haemoglobin levels and insulin dosage revealed 
no direct statistical relation to resistin levels. 
Conclusions: Diminished serum resistin concentrations and a negative correlation between resistin levels and body fat mass in children 
with type 1 diabetes seem to result from broken physiological adipo-insular regulations, independent of disease duration, its metabolic 
control and insulin supply. (Endokrynol Pol 2014; 65 (5):342–347)
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Streszczenie
Wstęp: Insulina jest jednym z głównych czynników regulujących funkcje tkanki tłuszczowej. Z drugiej strony, adipocyty wydzielają 
adipocytokiny, które mogą wpływać na sekrecję i działanie insuliny oraz brać udział w regulacji stężenia glukozy we krwi. W cukrzycy 
typu 1 sekrecja insuliny przez komórki beta zostaje zastąpiona przez egzogenną insulinoterapię. Powstaje pytanie o wpływ tej choroby na 
czynność sekrecyjną tkanki tłuszczowej. Celem pracy była ocena stężenia jednej z adipocytokin, rezystyny, w surowicy dzieci z cukrzycą 
typu 1, oraz związku oznaczonej rezystynemii z masą tkanki tłuszczowej.
Materiał i metody: Badaniami objęto 75 dzieci z cukrzycą typu 1, oraz grupę kontrolną 20 zdrowych dzieci. U wszystkich wykonano 
oznaczenia stężenia rezystyny w surowicy, poziomu hemoglobiny glikowanej, pomiary wzrostu i masy ciała, oraz badanie impedancji 
bioelektrycznej celem oceny składu ciała.
Wyniki: Stężenia rezystyny w surowicy były niższe u dzieci z cukrzycą typu 1 niż w grupie kontrolnej (mediana: 343 vs. 590 pg/ml, średnia 
± SD: 577 ± 561 vs. 861 ± 628 pg/ml, p < 0,001) oraz korelowały ujemnie z masą tkanki tłuszczowej (p = 0,022) oraz wiekiem (p = 0,022) 
w grupie dzieci z cukrzycą, ale nie w grupie kontrolnej. Czas trwania choroby, poziom hemoglobiny glikowanej i dawkowanie insuliny 
nie wykazały bezpośredniego związku statystycznego ze stężeniami rezystyny.
Wnioski: Obniżone stężenie rezystyny w surowicy oraz ujemna korelacja między stężeniami rezystyny i masą tłuszczową ciała u dzieci 
z cukrzycą typu 1 wydają się wynikać z przerwania fizjologicznych regulacji adipo-insularnych, niezależnie od czasu trwania choroby, 
jej kontroli metabolicznej i podaży insuliny. (Endokrynol Pol 2014; 65 (5): 342–347)
Słowa kluczowe: rezystyna; cukrzyca typu 1; tkanka tłuszczowa; insulina; dzieci
Introduction
Glucose plasma concentration under physiological 
conditions is maintained at a relatively constant level, 
despite the fact that carbohydrates are not continuously 
supplied in the diet. Maintaining such a state requires 
the consistent co-operation of several mechanisms.
One of the main roles is played by the beta cells 
of pancreatic islets. In the abundance of energy sub-
strates, they secrete insulin, which enables efficient 
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cellular glucose uptake, as well as its metabolism, or 
deposition as a reserve. On the other hand, when 
energetic substrates are deficient in the diet, low 
concentrations of insulin promote hepatic gluco-
neogenesis and glycogenolysis, as well as lipolysis 
in adipose tissue [1–3]. However, adipose tissue is 
not only a reservoir for energy excess, but also an 
endocrine organ. A number of biologically active 
substances it produces — adipocytokines — can both 
prevent hyperglycaemia (such as leptin, adiponectin) 
and promote it (TNF-α, most other cytokines) [4–8]. 
The importance of adipose tissue for carbohydrate 
management is confirmed by clinical observations 
— both its excess (obesity) and deficiency (including 
lipodystrophy) are associated with insulin resistance 
and a tendency to elevated glucose levels [1, 9].
One of the adipocytokines is resistin — a protein 
hormone that seems to be involved in the process of 
blood glucose regulation, although its biological func-
tion in humans has not been fully identified yet [10, 11]. 
Studies carried out on rodent models have dem-
onstrated that resistin intensifies gluconeogenesis and 
glycogenolysis — increasing hepatic insulin resistance 
and elevating blood glucose levels. Chronic hyperre-
sistinaemia observed in rats leads to a systemic insulin 
resistance, involving skeletal muscles and adipose 
tissue, and it results in glucose intolerance, hyperinsu-
linaemia and hypertriglyceridaemia [1, 4, 12–15]. The 
physiological role of resistin may be maintaining blood 
glucose level during nutritional deficiencies, while its 
pathological effects seem to be associated with worsen-
ing of glucose utilisation in a state of body fat excess. 
Resistin concentrations increase in diet-induced obesity 
and in biological models of genetically determined 
obesity as well [13, 16].
On the other hand, suppression of resistin activ-
ity in rodents exacerbates adipogenesis and causes 
a consequent increase in adipose tissue mass, along 
with an enhancement in insulin sensitivity and glu-
cose use [17].
In type 1 diabetes, a number of biological pro-
cesses responsible for the regulation of blood glu-
cose level are impaired as a result of the absence of 
endogenously produced insulin — its physiological 
function is replaced by the exogenous supply, which 
is not regulated naturally. This raises a number of 
questions concerning the impact of type 1 diabetes 
on adipose tissue secretory function. Its disorders 
may, among others, increase the already increased 
risk of premature atherosclerosis in children and 
adolescents with type 1 diabetes [18, 19].
The aim of this study was to establish resistin serum 
concentrations, and its relation to body fat mass, in 
children with type 1 diabetes mellitus. 
Material and methods
The study included 75 children with type 1 diabetes: 
30 boys and 45 girls aged four to 17 years with disease 
duration from one to 15 years (Table I). The patients were 
in generally good condition, with no acute or chronic com-
plications of diabetes or additional diseases. In the studied 
group, 35 patients were treated with intensive functional 
insulin therapy, 21 with continuous subcutaneous insulin 
infusion, and 19 with the conventional method.
The control group included 20 healthy children: ten 
boys and ten girls, aged six to 16 years (mean value ± 
SD: 12.5 ± 2.7).
The following investigations were performed in all 
children at basic conditions — in the morning, fasting, 
after a night’s rest: 
 — blood sample obtained to determine resistin serum 
concentrations and glycated haemoglobin (HbA1c) levels; 
 — growth and body weight measurements (accurate 
to 0.1 cm and 0.1 kg, respectively); 
 — bioelectrical impedance analysis (BIA) in order to 
evaluate body composition (Akern analyser BIA-101, 
Bioresearch, the tetrapolar system [20]).
Serum resistin concentration was determined with 
the radioimmunoassay method (Resistin (43–65) (Hu-
man) RIA Kit, Phoenix Pharmaceuticals).
Values of glycated haemoglobin (HbA1c) were ob-
tained with high-performance liquid chromatography 
— HPLC (Bio-Rad).
The statistical study quantitative traits have been 
characterised by applying the mean value and standard 
deviation (SD). Kolmogorov-Smirnov test was used in 
evaluating the compatibility of the variables with the 
normal distribution. For the variables not compatible 
with the normal distribution, nonparametric methods 
were used: Mann-Whitney test to determine differences 
in quantitative traits between the two groups, and the 
Spearman correlation r, in order to assess the coincidence 
between two quantitative traits. For normally distributed 
Table I. Clinical characteristics of patients with type 1 
diabetes (N = 75)
Tabela I. Charakterystyka kliniczna grupy pacjentów 
z cukrzycą typu 1 (N = 75)
Mean ± SD
Age (years) 12.5 ± 3.5
Diabetes duration (years) 4.9 ± 3.1
HbA1c (%) 7.7 ± 1.4
INS/day [units/day] 42.2 ± 21.1
INS/kg [units/kg] 0.85 ± 0.28
HbA1c — glycated haemoglobin; INS/day — daily insulin dose; INS/kg — daily 













Serum resistin concentrations in children with type 1 diabetes mellitus  Katarzyna Anna Majewska et al.
variables, parametric methods were used: Levene’s test of 
homoscedasticity and t-test to assess the equality of average 
differences between groups, and Pearson correlations to 
determine the relationship between two quantitative traits. 
Statistical study was performed in SPSS for Windows 14.0.
The study protocol was approved by the local Eth-
ics Committee of the Karol Marcinkowski University 
of Medical Sciences in Poznań. Legal guardians of all 
participants gave informed consent.
Results
Fat mass analysis
Fat mass values determined with bioelectrical imped-
ance analysis revealed no statistically significant differ-
ences between the groups. A comparative statement of 
the elements of body composition of children with dia-
betes and their healthy coevals is presented in Table II.
In both the studied and the control group, the amount 
of fat mass differed depending on the sex: both its total 
value (FM) and percentage value (compared to the total 
body weight) of the body fat mass (FM%) was significantly 
higher in girls than in boys with diabetes (for both features: 
p < 0.001). In the control group, a statistically significant 
difference was only presented by the parameter FM% 
(p = 0.009), while for the FM no statistical significance was 
achieved (p = 0.282) in spite of the observed tendency for 
slightly higher values in females. 
In the group of children with diabetes, statistical 
analysis showed a significant, direct dependency of 
total body fat mass on age and duration of disease, 
while its value of interest (FM%) did not show a similar 
dependency. 
In the control group, no statistically significant rela-
tion between age and either FM (p = 0.415) or FM% 
(p = 0.072) was demonstrated.
Glycated haemoglobin, as a parameter of metabolic 
control in diabetic patients, showed no statistical as-
sociation with body fat mass. 
Table II. Body mass and its components in children with type 
1 diabetes and the control group, as assessed by bioelectrical 
impedance
Tabela II. Masa ciała oraz jej składniki u dzieci z cukrzycą 
i zdrowych, oznaczone metodą impedancji bioelektrycznej
Type 1 diabetes  
(N = 75)
Control group  
(N = 20)
P value
mean ± SD mean ± SD
BW [kg] 47.7 ± 15.2 45.8 ± 10.3 > 0.05
MM [kg] 21.8 ± 7.7 22.0 ± 6.8 > 0.05
MM% (%) 45.5 ± 5.9 47.5 ± 5.7 > 0.05
FM [kg] 11.6 ± 5.8 10.5 ± 3.7 > 0.05
FM% (%) 24.5 ± 8.0 23.4 ± 7.1 > 0.05
FFM [kg] 36.1 ± 12.3 35.3 ± 9.3 > 0.05
FFM% (%) 75.5 ± 8.0 76.6 ± 7.1 > 0.05
BW — body weight; MM — total body muscle mass; MM% — percentage value of 
the body muscle mass; FM — total body fat mass; FM% — percentage value of the 
body fat mass; FFM — total body fat free mass; FFM% — percentage value of the 
body fat free mass. No statistically significant differences between the groups
Table III. Correlations of total body fat mass (FM) and its percentage value (FM%) with the clinical data of patients with 
type 1 diabetes mellitus
Tabela III. Korelacje całkowitej masy tłuszczowej ciała (FM) oraz jej wartości procentowej (FM%) z danymi klinicznymi 
u dzieci z cukrzycą typu 1
 
FM [kg] FM% (%)
R P value R P value
Age (years) 0.491 < 0.001 –0.157 0.179
Diabetes duration (years) 0.330 0.004 0.076 0.518
HbA1c (%) 0.089 0.449 0.068 0.565
INS/day [units/day] 0.541 < 0.001 0.001 0.994
INS/kg [units/kg] 0.238 0.039 0.019 0.874
HbA1c — glycated haemoglobin; INS/day — daily insulin dose; INS/kg — daily insulin dose per kg of body weight.
A statistically significant correlation was found in 
the case of insulin doses used in the treatment — a total 
daily insulin dose (INS/day) and the calculated dose 
per kilogram of body weight (INS/kg) showed a direct 
relationship with the total fat mass, but no relationship 
with the percentage amount of body fat. The used 
method of insulin therapy did not show a statistical 
relationship between body fat mass of children and 
adolescents and type 1 diabetes. Correlations of body 
fat mass (FM and FM%) with the clinical data of patients 
with type 1 diabetes mellitus are presented in Table III.
Resistin concentration analysis
Statistical analysis demonstrated a significant difference 
in the resistinaemia between the patients and the control 
group (p < 0.001). Children with diabetes had lower re-
345












sistin concentrations than their healthy coevals (median 
value: 343 vs. 590 pg/mL, and mean values ± SD: 577 ± 
561 pg/mL vs. 861 ± 628 pg/mL respectively) (Figs. 1–3).
The assessment of the resistin concentrations de-
pendence on body composition in children with diabe-
tes showed a negative correlation with the total fat mass 
(FM) as determined with bioelectrical impedance, with 
no relation to the percentage value (FM%), or the total 
body weight. None of these correlations was observed 
in the control group. 
In neither of the groups, namely patients with dia-
betes and healthy children in the control group, were 
statistically significant gender-related differences in 
resistinaemia found. 
The resistin concentrations observed in the diabetic 
group presented a statistically significant, inversely pro-
portional dependence on age — along with the advance-
ment of age the resistinaemia value decreased. Such 
dependence was not observed in the control group.
Neither the duration of diabetes nor its metabolic 
control, measured as the glycated haemoglobin value, 
showed statistically significant dependence on the 
concentrations of resistin. The evaluation of the re-
lationship between resistinaemia and the individual 
daily dose of insulin in patients with diabetes showed 
no correlation with any of the applicable conversion 
methods (INS/day, INS/kg). Resistin concentrations 
showed no dependence on the method of insulin 
therapy.
Correlations of serum resistin concentrations with 
clinical data are presented in Table IV.
Discussion
Despite studies showing a significant role of resistin in 
the development of insulin resistance in rodents, its role 
in humans is still not fully understood. Research projects 
carried out with different groups of patients have tried to 
answer questions about the role of resistin in, among oth-
ers, the pathogenesis of insulin resistance, inflammation 
and related diseases [4]. Also, the impact of type 1 diabetes 
mellitus on resistin secretion remains unclear.
Fehman et al., comparing resistin concentrations 
in patients with type 1 diabetes, type 2 diabetes and 
healthy individuals, found similar levels in all subjects 
[21]. On the other hand, Schäffler et al., in a large study 
of 555 adult patients with type 2 diabetes, 114 patients 
with type 1 diabetes, and 216 healthy subjects, reported 
significantly higher resistin concentrations in healthy 
Figure 1. Mean values of resistin serum concentrations [pg/ml] 
in children with type 1 diabetes and the control group
Rycina 1. Średnie stężenia rezystyny w surowicy [pg/ml] u dzieci 
z cukrzycą typu 1 i w grupie kontrolnej
Figure 2. Histograms for resistin serum concentrations in children with type 1 diabetes (N = 75)













Serum resistin concentrations in children with type 1 diabetes mellitus  Katarzyna Anna Majewska et al.
subjects in the control group than in patients with type 
1 and type 2 diabetes, without a significant impact of 
age and sex on the obtained results [22]. 
Martos-Moreno et al. evaluated resistin concentra-
tions in children in the early stages of type 1 diabetes 
before commencing insulin therapy, and after one and 
four months of treatment. Their results showed no 
difference, while the concentrations were similar to 
those obtained in the control group at all time points 
[23]. Furthermore, in the study by Celi et al., the resistin 
levels observed in children with type 1 diabetes were 
lower than in their healthy peers [24].
Resistinaemia in diabetic patients in our study pre-
sented significantly lower values than in the healthy 
subjects in the control group. 
As resistin is one of the adipocytokines, we analysed 
its concentrations together with body fat mass, to then 
evaluate the mutual correlations. 
In the studied group of children with type 1 dia-
betes, results obtained with bioelectrical impedance 
analysis showed similar body fat mass to those in the 
control group. 
In both groups, a significant association between 
the fat mass and gender was confirmed, showing that 
its contents are higher among girls, while no gender-
related differences in resistinaemia were found.
The lack of significant differences in terms of body 
fat mass between the children with diabetes treated 
with different methods (i.e. conventional, intensive 
functional insulin therapy, or continuous subcutaneous 
insulin infusion) and the presence of a positive correla-
tion between fat mass and both the total daily insulin 
dose and the dose converted per kilogram of body 
weight, indicate the importance of total insulin dose 
sizes for adipose tissue mass gain, and not its distribu-
tion pattern throughout the day. 
In the group of children with diabetes, no relation-
ship was found between fat mass and metabolic control 
of the disease, assessed with the glycated haemoglobin 
value, but a positive correlation with age and duration 
of diabetes was demonstrated. In the control group, 
however, the dependence of fat mass on age did not 
reach statistical significance. This may suggest that the 
strong correlation between age and fat mass observed 
in children with diabetes is related to the disease dura-
Figure 3. Histograms for resistin serum concentrations in control group (N = 20)
Rycina 3. Histogramy dla stężeń rezystyny w surowicy w grupie kontrolnej (N = 20)
Table IV. Correlations of serum resistin concentrations with 
clinical data among analysed groups
Tabela IV. Korelacje stężeń rezystyny w surowicy z danymi 
klinicznymi w analizowanych grupach
 
Type 1 diabetes Control group
R p-value R p-value
Age (years) –0.265 0.022 –0.273 0.244
BW [kg] –0.216 0.063 –0.323 0.165
FM [kg] –0.265 0.022 0.021 0.930
FM% (%) –0.110 0.349 0.215 0.362
Diabetes duration 
(years)
–0.095 0.416 – –
HbA1c (%) –0.072 0.538 – –
INS/day [units/day] –0.314 0.320 – –
INS/kg [units/kg] –0.034 0.772 – –
BW — body weight; FM — total body fat mass; FM% — percentage 
value of the body fat mass; INS/day — daily insulin dose; INS/kg — 
daily insulin dose per kg of body weight
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tion, and thus to the chronic exogenous insulin therapy 
and peripheral hyperinsulinaemia.
Resistin is considered to be the adipocytokine the physi-
ological role of which is to maintain the blood glucose level 
during hunger [13]. In patients with type 1 diabetes, due to 
the imperfections of treatment, hyperglycaemia is a com-
mon phenomenon. At high glucose serum concentrations, 
the hyperglycaemic effect of resistin, treated as ‘redundant’, 
may be subject to suppression by inhibiting its secretion. 
The mechanisms controlling production and secretion 
of resistin in the adipose tissue are not clear, although in 
adipocytes cultured in vitro, Haugen et al. observed a sig-
nificant reduction in the amount of resistin mRNA under 
the influence of increasing concentrations of insulin [25]. 
This observation was consistent with the results of a study 
conducted by Liu et al. [26], thus hyperinsulinaemia, which 
frequently appears in patients with type 1 diabetes, could 
also exert an inhibitory effect on the secretion of resistin, 
resulting in its reduced levels in these patients.
In children with diabetes in the studied group, 
a negative correlation between resistin levels and body 
fat mass was demonstrated. Furthermore, a negative 
correlation between resistinaemia and age was observed. 
These results might be explained by the varied maturity 
of adipocytes. In the studies carried out on tissue cultures 
of human preadipocytes, resistin levels are high, while in 
the cultures of mature adipocytes they are very low [1, 
4]. From this it follows that more resistin should be pro-
duced in less mature adipose tissue, with relatively more 
preadipocytes. An increased amount of adipose tissue 
and a more advanced age of patients may be associated 
with its greater maturity and, probably, lower secretion 
of resistin. However, this correlation was not found in 
healthy children, so the impact of type 1 diabetes should 
be considered. Despite the ‘missing’ correlation of resistin 
concentration and insulin doses, chronic hyperinsulinae-
mia in diabetic patients might be at least one of the factors 
influencing diminished serum resistin levels — insulin 
dose is not equal with insulin serum concentration, nor 
is its actual activity, when also insulin resistance and anti-
insulin antibodies are taken into consideration.
There is an unresolved question whether the reduced 
serum resistin levels observed in children and adolescents 
with type 1 diabetes are related to disorders in insulin 
sensitivity — future research in this field should include si-
multaneous and objective evaluation of insulin resistance.
Conclusions
Type 1 diabetes mellitus induces diminished serum 
resistin concentrations in fasting children and adoles-
cents. It also reveals a negative correlation between 
resistin levels and body fat mass, which was not ob-
served in healthy children. These findings seem to result 
from broken physiological adipo-insular regulations in 
type 1 diabetes, independent of disease duration, its 
metabolic control and insulin supply. To clarify the exact 
mechanisms and possible relation to the state of insulin 
resistance, further investigations would be required.
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